Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY)

Market Cap	8.26B -4.3%
Revenue (ttm)	42.61B +4.3%
Net Income	702.23M -21.4%
EPS	0.19 -21.4%
Shares Out	n/a
PE Ratio	11.76
Forward PE	9.64
Dividend	0.29 (4.03%)
Ex-Dividend Date	Sep 17, 2026

Volume	100
Open	7.04
Previous Close	7.24
Day's Range	7.04 - 7.24
52-Week Range	7.04 - 8.32
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About SHPMY

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1994
• Employees: 48,640
• Stock Exchange: OTCMKTS
• Ticker Symbol: SHPMY

Financial Performance

In 2025, SHPMY's revenue was 283.58 billion, an increase of 3.03% compared to the previous year's 275.25 billion. Earnings were 5.72 billion, an increase of 25.74%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 4, 2026

Data Sources Report a data error